Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
New genetic markers may lead to personalized treatments for lung cancer

New genetic markers may lead to personalized treatments for lung cancer

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

High expression of cell death genes may increase risk of early death from lung cancer

High expression of cell death genes may increase risk of early death from lung cancer

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

NCCN Annual Conference discusses new ways to improve cancer care

NCCN Annual Conference discusses new ways to improve cancer care

Novel method can improve the detection of circulating tumor cells

Novel method can improve the detection of circulating tumor cells

Newly identified biomarker could predict response to immune checkpoint inhibitors

Newly identified biomarker could predict response to immune checkpoint inhibitors

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Researchers use cachexia model to assess cancer-derived myocardial impairments

Researchers use cachexia model to assess cancer-derived myocardial impairments

AI technology can help prevent adverse effect of immunotherapy in certain lung cancer patients

AI technology can help prevent adverse effect of immunotherapy in certain lung cancer patients

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

LCMC3 trial: Neoadjuvant atezolizumab prior to lung cancer surgery meets primary endpoint

LCMC3 trial: Neoadjuvant atezolizumab prior to lung cancer surgery meets primary endpoint

Residential segregation, discriminatory practices impact outcomes of Black lung cancer patients

Residential segregation, discriminatory practices impact outcomes of Black lung cancer patients

New approach to capture natural killer cells and harvest cancer-killing packets

New approach to capture natural killer cells and harvest cancer-killing packets

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Missing surface protein allows small cell lung cancer cells to hide from immune defenses

Missing surface protein allows small cell lung cancer cells to hide from immune defenses

Researchers develop comprehensive framework to classify small-cell lung cancer

Researchers develop comprehensive framework to classify small-cell lung cancer

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Study uncovers why cancer patients with liver metastases have poor outcomes

Study uncovers why cancer patients with liver metastases have poor outcomes